Advancing RNA Amplification Technologies for Microarrays

Information

  • Research Project
  • 6551851
  • ApplicationId
    6551851
  • Core Project Number
    R44GM062083
  • Full Project Number
    2R44GM062083-02
  • Serial Number
    62083
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/2000 - 23 years ago
  • Project End Date
    8/14/2005 - 18 years ago
  • Program Officer Name
    HEART, LUNG, AND BLOOD INST., NATIONAL
  • Budget Start Date
    8/15/2002 - 21 years ago
  • Budget End Date
    8/14/2003 - 20 years ago
  • Fiscal Year
    2002
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/27/2002 - 21 years ago
Organizations

Advancing RNA Amplification Technologies for Microarrays

DESCRIPTION (provided by applicant): Probably the most versatile assay for genomic scale research is the high-density microarray. Microarray analysis has the potential for uncovering the complex behavior of gene expression. Microarray trends are becoming established which includes higher throughput and a need to analyze pg quantities of mRNA. This proposal is focused on one aspect of microarray technology (aRNA amplification) which plans to meet the observed trends of the industry. The current multi-step amplification process introduces a source of variability, time and expense. As the amount of input mRNA is lowered, likewise, confidence is reduced and the array experiments themselves have questionable validity. We recognized this limitation as an opportunity that our research group should study, specifically, how can we use our expertise and our supply of high quality transcription reagents to establish a R&D program to enhance the performance of RNA amplification methods? We will design an exhaustive optimization plan to explore a large matrix of conditions, work that is most suitable for a robotic platform. Careful microarray analysis with numerous internal controls will be used to monitor the progress of the optimization program to insure that the representation is accompanied enhanced yields. The optimized enzymatic steps will be integrated on to automated platforms, which will increase the throughput and consistency of the method for research demanding a large number of samples. The effort spent creating the robotic program will serve two purposes. First, it will allow us to screen a large space of reaction conditions (finding optimal reactants) it also be instrumental for creating the next versions of RNA amplification kits, specifically for common robots. The goal of the larger study is to further optimize each step of the method for the commercialization of kits, robotic reagent packages and finally a microfluidic device and accompanying reagents.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    903638
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:903638\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    AMBION, INC.
  • Organization Department
  • Organization DUNS
    198680068
  • Organization City
    AUSTIN
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    787441832
  • Organization District
    UNITED STATES